enow.com Web Search

  1. Ads

    related to: high risk drugs for teens with diabetes 1 and 2 similarities youtube full

Search results

  1. Results from the WOW.Com Content Network
  2. More teens are turning to weight loss drugs, though some ...

    www.aol.com/news/more-teens-turning-weight-loss...

    Demi and Brenden are part of a growing number of teens turning to powerful new weight loss medications. According to data from health care analytics platform PurpleLab, in 2023, about 4,000 ...

  3. Diabetes medication - Wikipedia

    en.wikipedia.org/wiki/Diabetes_medication

    Drugs used in diabetes treat types of diabetes mellitus by decreasing glucose levels in the blood. With the exception of insulin , most GLP-1 receptor agonists ( liraglutide , exenatide , and others), and pramlintide , all diabetes medications are administered orally and are thus called oral hypoglycemic agents or oral antihyperglycemic agents.

  4. Semaglutide - Wikipedia

    en.wikipedia.org/wiki/Semaglutide

    The study focused on metformin and GLP-1 drugs, including semaglutide, tirzepatide and liraglutide. Among nearly 13,000 individuals with both diabetes and asthma, metformin lowered the risk of asthma attacks by 30%, and adding a GLP-1 drug further reduced it by 40%. [121]

  5. Alpha-glucosidase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Alpha-glucosidase_inhibitor

    In patients with diabetes mellitus type 1, alpha-glucosidase inhibitors use has not been officially approved by the Food and Drug Administration in the US but some data exists on the effectiveness in this population, showing potential benefits weighted against an increased risk of hypoglycemia. [18]

  6. Lilly's weight-loss drug cuts diabetes risk in overweight ...

    www.aol.com/news/eli-lillys-weight-loss-drug...

    (Reuters) -Eli Lilly's weight-loss drug, Zepbound, drastically cut the risk of developing type 2 diabetes in overweight or obese pre-diabetic adults after three years of weekly injections, the ...

  7. SGLT2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/SGLT2_inhibitor

    Sotagliflozin (Inpefa) is a dual SGLT1/SGLT2 inhibitor approved by the US Food and Drug Administration (FDA) in May 2023, to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors.

  8. CDC report finds teens are using drugs — often alone — to ...

    www.aol.com/news/cdc-report-finds-teens-using...

    It's important to understand why teens use or misuse drugs, so the right resources and education can help them, Dr. Nora Volkow, director of the National Institute on Drug Abuse, wrote in an email.

  9. Type 1 diabetes - Wikipedia

    en.wikipedia.org/wiki/Type_1_diabetes

    In the general population, the risk of developing type 1 diabetes is around 1 in 250. For someone whose parent has type 1 diabetes, the risk rises to 1–9%. If a sibling has type 1 diabetes, the risk is 6–7%. If someone's identical twin has type 1 diabetes, they have a 30–70% risk of developing it themselves. [38]

  1. Ads

    related to: high risk drugs for teens with diabetes 1 and 2 similarities youtube full